# Integra LifeSciences to acquire Surgical Innovation Associates for up to $140M

Integra LifeSciences has entered a definitive agreement to acquire Surgical Innovation Associates (SIA), which manufactures DuraSorb absorbable mesh for plastic and reconstructive surgery. The deal is valued at up to $140 million, with $50 million at closing and up to $90 million in milestones.

- Type: Acquisition
- Announced: 2022-12-01
- Where: United States
- Value: $140.0M
- Status: announced
- Products: DuraSorb absorbable monofilament mesh
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Integra LifeSciences](https://endata.com/companies/21365.md) (acquirer)
- [Surgical Innovation Associates](https://endata.com/companies/67023.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20221201005036/en/Surgical-Innovation-Associates-SIA-Announces-Definitive-Agreement-to-be-Acquired-by-Integra-LifeSciences), 2022-12-01: "Integra LifeSciences warrants great respect among physicians, and shares SIA’s origins in plastic surgery."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.